The UK government is under pressure to remove controversial American company Palantir from NHS England data systems and is exploring options to trigger a break clause in its contract.

Review finds evidence does not back use of treatment for 16 and 17-year-olds with gender incongruence or dysphoria The NHS is pausing new referrals for masculinising or feminising hormone treatment for 16 and 17-year-olds after an in-depth review found there was insufficient evidence to support its continued use. Prescriptions for hormones had been available in England for under-18s with a diagnosis of gender incongruence or dysphoria who met certain criteria. Continue reading...

GXO Logistics experienced gains in its stock value after successfully securing a new healthcare contract with NHS England.

Health justice charity Medact says data-sharing potential could be used for UK version of US immigration raids Palantir’s NHS contract opens the door to the Big Brother-style data-sharing that Reform UK would use for a version of US immigration raids, health bosses have been told. Palantir Technologies – the data analytics company founded by Peter Thiel and Alex Karp – won a £330m NHS England contract to deliver the Federated Data Platform in 2023. Continue reading...

Ministers in England are planning to set targets for the NHS to help people return to work, alongside linking patient data to benefit claims and employment statistics.

The NHS in England is projected to miss crucial targets for reducing waiting times in A&E, cancer care, and planned hospital treatments, with critics attributing the failures to the recent NHS England restructure.

The health service said young people who already receive the drugs will continue to do so.